FFS
CEROW

Fortress Financial Solutions’s CERo Therapeutics Warrants CEROW Stock Holding History

Fortress Financial Solutions’s Portfolio CEROW Stock Details CEROW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,000
Closed -$133 – 65
2025
Q3 		$133 Hold
10,000
– – ﹤0.01% 60
2025
Q2 		$238 Buy
+10,000
New +$155 ﹤0.01% 63

Other funds holding CEROW

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Fortress Financial Solutions's CEROW Position: Q4 2025 in Review

Fortress Financial Solutions sold out of CERo Therapeutics Warrants (CEROW) in Q4 2025, closing a stake of 10,000 shares — an estimated $133 sold.

Fortress Financial Solutions first reported a position in CEROW in Q2 2025 and held it in 2 quarters. The position peaked at $238 in Q2 2025. 1 fund tracked by Wall St. Rank holds CEROW as of Q4 2025.

  • Fortress Financial Solutions reported no remaining CERo Therapeutics Warrants position as of Q4 2025 after selling out during the quarter.
  • Fortress Financial Solutions sold 10,000 CERo Therapeutics Warrants shares in Q4 2025, an estimated $133.
  • Fortress Financial Solutions first reported a position in CERo Therapeutics Warrants in Q2 2025 and held it in 2 quarters.
  • Fortress Financial Solutions's CERo Therapeutics Warrants position peaked at $238 in Q2 2025.
  • 1 fund tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q4 2025.

Based on Fortress Financial Solutions's 13F filing for Q4 2025, filed 23 Jan 2026.